Shattuck Labs (STTK) Retained Earnings (2019 - 2026)
Shattuck Labs' (STTK) quarterly Retained Earnings came in at -$445.3 million in Q1 2026, down 12.62% year-on-year from -$509.6 million in Q1 2025, and down 3.43% on a QoQ basis from -$430.5 million in Q4 2025.
Shattuck Labs (STTK) Retained Earnings (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Retained Earnings data on file, last reported at -$445.3 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 12.62% year-over-year to -$445.3 million in Q1 2026; TTM through Mar 2026 was -$445.3 million, a 12.62% decrease from a year earlier, with the FY2025 full-year figure at -$430.5 million, down 12.79% from the prior year.
- Retained Earnings for Q1 2026 stood at -$445.3 million, down from -$430.5 million in the prior quarter.
- Over the last five years, Retained Earnings for STTK reached as high as $457.0 million in Q2 2024 and fell as low as -$445.3 million in Q1 2026.
- Historically, Retained Earnings has averaged -$99.5 million across 5 years, with a median of -$193.6 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 617643.24% in 2024 and fell as far as 5186400.0% in 2024.
- Year by year, Retained Earnings stood at -$877000.0 in 2022, then surged by 51526.0% to $451.0 million in 2023, then slumped by 184.64% to -$381.7 million in 2024, then retreated by 12.79% to -$430.5 million in 2025, then slipped by 3.43% to -$445.3 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$445.3 million in Q1 2026, -$430.5 million in Q4 2025, and -$417.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -445.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -445.30 Mn |
| Dec 31, 2025 | -430.53 Mn |
| Sep 30, 2025 | -417.94 Mn |
| Jun 30, 2025 | -407.88 Mn |
| Mar 31, 2025 | -395.40 Mn |
| Dec 31, 2024 | -381.72 Mn |
| Sep 30, 2024 | -363.04 Mn |
| Jun 30, 2024 | 456.98 Mn |
| Mar 31, 2024 | 453.64 Mn |
| Dec 31, 2023 | 451.01 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | -239.70 Mn |
| Dec 31, 2022 | -877,000.00 |
| Sep 30, 2022 | -193.60 Mn |
| Jun 30, 2022 | -168.97 Mn |
| Mar 31, 2022 | 391.06 Mn |
| Dec 31, 2021 | -117.07 Mn |
| Sep 30, 2021 | -1.83 Mn |
| Jun 30, 2021 | -1.62 Mn |